Myriad Genetics Inc (MYGN)
21.32
-0.08
(-0.37%)
USD |
NASDAQ |
Mar 28, 16:00
21.31
-0.01
(-0.05%)
After-Hours: 20:00
Myriad Genetics Free Cash Flow (Quarterly): -68.20M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -68.20M |
September 30, 2023 | -39.60M |
June 30, 2023 | -19.70M |
March 31, 2023 | -56.70M |
December 31, 2022 | -21.90M |
September 30, 2022 | -20.50M |
June 30, 2022 | -56.40M |
March 31, 2022 | -52.80M |
December 31, 2021 | -12.90M |
September 30, 2021 | -42.30M |
June 30, 2021 | -8.90M |
March 31, 2021 | 64.70M |
September 30, 2020 | -60.80M |
June 30, 2020 | 27.60M |
March 31, 2020 | 13.80M |
December 31, 2019 | -5.30M |
September 30, 2019 | 14.40M |
June 30, 2019 | 30.10M |
March 31, 2019 | 3.50M |
December 31, 2018 | 35.00M |
September 30, 2018 | 6.50M |
June 30, 2018 | 46.10M |
March 31, 2018 | 8.60M |
December 31, 2017 | 30.90M |
September 30, 2017 | 21.90M |
Date | Value |
---|---|
June 30, 2017 | 35.90M |
March 31, 2017 | 39.60M |
December 31, 2016 | 29.00M |
September 30, 2016 | -4.40M |
June 30, 2016 | 36.30M |
March 31, 2016 | 45.20M |
December 31, 2015 | 51.00M |
September 30, 2015 | 28.80M |
June 30, 2015 | 49.00M |
March 31, 2015 | 25.50M |
December 31, 2014 | 46.60M |
September 30, 2014 | -4.50M |
June 30, 2014 | 36.27M |
March 31, 2014 | 9.694M |
December 31, 2013 | 44.72M |
September 30, 2013 | 85.22M |
June 30, 2013 | 60.22M |
March 31, 2013 | 35.82M |
December 31, 2012 | 17.57M |
September 30, 2012 | 48.90M |
June 30, 2012 | 39.51M |
March 31, 2012 | 38.75M |
December 31, 2011 | 23.67M |
September 30, 2011 | 29.72M |
June 30, 2011 | 35.36M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-68.20M
Minimum
Dec 2023
64.70M
Maximum
Mar 2021
-16.42M
Average
-19.70M
Median
Jun 2023
Free Cash Flow (Quarterly) Benchmarks
Stryker Corp | 1.383B |
Integer Holdings Corp | 18.53M |
Haemonetics Corp | -22.83M |
Perspective Therapeutics Inc | -10.34M |
Electromed Inc | 3.384M |